Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.1 NOK | -8.51% | +3.44% | +21.37% |
Mar. 05 | Transcript : Nordhealth AS, Q4 2023 Earnings Call, Mar 05, 2024 | |
Mar. 05 | Nordhealth AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 44.94M 48.4M 525M | Sales 2025 * | 53.23M 57.33M 621M | Capitalization | 204M 219M 2.38B |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.54M -81.71M | Net income 2025 * | -1M -1.08M -11.67M | EV / Sales 2024 * | 3.98 x |
Net cash position 2024 * | 24.7M 26.6M 288M | Net cash position 2025 * | 29.22M 31.47M 341M | EV / Sales 2025 * | 3.28 x |
P/E ratio 2024 * |
-25.8
x | P/E ratio 2025 * |
-129
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.53% |
Latest transcript on Nordhealth
1 day | -8.51% | ||
1 week | +3.44% | ||
Current month | -7.95% | ||
1 month | -11.47% | ||
3 months | +20.40% | ||
6 months | +20.88% | ||
Current year | +21.37% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-12-31 | |
Chief Executive Officer | - | 17-12-31 | |
Director of Finance/CFO | - | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Didier Breton
CHM | Chairman | 71 | 20-12-31 |
Philippe Vimard
BRD | Director/Board Member | 50 | 23-04-23 |
Founder | - | 00-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 30.1 | -8.51% | 2,475 |
24-05-08 | 32.9 | +5.45% | 3,445 |
24-05-07 | 31.2 | +5.76% | 100,003 |
24-05-06 | 29.5 | +1.37% | 2,795 |
24-05-03 | 29.1 | +0.34% | 1 |
Real-time Oslo Bors, May 10, 2024 at 10:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.37% | 239M | |
+5.85% | 32.95B | |
+20.16% | 8.09B | |
+30.81% | 4B | |
-25.95% | 3.09B | |
-19.96% | 1.39B | |
-31.87% | 1.19B | |
+8.02% | 966M | |
-35.73% | 933M | |
-25.74% | 834M |
- Stock Market
- Equities
- NORDH Stock